PAhR Therapeutics Overview
- Year Founded
-
2025
- Status
-
Private
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$14M
- Investors
-
3
PAhR Therapeutics General Information
Description
Operator of a clinical-stage biotechnology company intended to develop novel therapies for pulmonary arterial hypertension through molecular mechanisms. The company offers cutting-edge treatments targeting the molecular pathophysiology of PAH, enabling customers to access potentially life-saving therapies that address unmet needs in PAH treatment, offering new hope where conventional options fall short.
Contact Information
Website
www.pahrtx.comCorporate Office
- 200 Berkeley Street
- Floor 18
- Boston, MA 02116
- United States
Corporate Office
- 200 Berkeley Street
- Floor 18
- Boston, MA 02116
- United States
PAhR Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 28-Jul-2025 | $14M | Completed | Pre-Clinical Trials |
PAhR Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
PAhR Therapeutics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AN Venture Partners | Venture Capital | Minority | ||
| RA Capital Management | Asset Manager | Minority | ||
| The University of Tokyo Edge Capital | Venture Capital | Minority |
PAhR Therapeutics FAQs
-
When was PAhR Therapeutics founded?
PAhR Therapeutics was founded in 2025.
-
Where is PAhR Therapeutics headquartered?
PAhR Therapeutics is headquartered in Boston, MA.
-
What industry is PAhR Therapeutics in?
PAhR Therapeutics’s primary industry is Drug Discovery.
-
Is PAhR Therapeutics a private or public company?
PAhR Therapeutics is a Private company.
-
What is the current valuation of PAhR Therapeutics?
The current valuation of PAhR Therapeutics is .
-
What is PAhR Therapeutics’s current revenue?
The current revenue for PAhR Therapeutics is .
-
How much funding has PAhR Therapeutics raised over time?
PAhR Therapeutics has raised $14M.
-
Who are PAhR Therapeutics’s investors?
AN Venture Partners, RA Capital Management, and The University of Tokyo Edge Capital have invested in PAhR Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process